9:00 AM - 5:00 PM

Our Hours Mon. - Fri.

310.774.1437

Call Us For Free Consultation

Facebook

Twitter

Cooley Guides Cancer-Focused Biotech’s $115M IPO Filing

Tiomkin Law Offices of Elliott Tiomkin > Legal News  > Cooley Guides Cancer-Focused Biotech’s $115M IPO Filing

Cooley Guides Cancer-Focused Biotech’s $115M IPO Filing

Law360 (January 7, 2019, 7:40 PM EST) — Early-stage biotechnology firm Poseida Therapeutics Inc., which is developing therapies for multiple myeloma and prostate cancer, said in a late Friday filing with the U.S. Securities and Exchange Commission that it…

Call Now ButtonCall For Free Consultation